This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.
Hepatitis B Virus (HBV) primarily affects the liver, leading to severe health conditions such as cirrhosis and liver cancer. Despite the absence of symptoms in some individuals, a blood test is essential for diagnosis.
The World Health Organisation estimates that over 350 million people globally have chronic HBV infections. High prevalence areas include sub-Saharan Africa, Asia, and the Pacific islands, contrasting with the UK's low prevalence.
HBV is notably more infectious than HIV, surviving outside the body for up to 7 days or more. Transmission occurs through sexual contact, sharing needles, from mother to child during birth, and occupational exposures.
A safe and effective vaccine against HBV is available and administered in three doses over six months. Unlike other vaccinations, HBV does not require booster shots as immunity persists indefinitely post-immunisation.
Professionals exposed to bloodborne pathogens, including first aid administrators, medical and dental office workers, and those involved in the clean-up of potentially infectious materials, are advised to receive the HBV vaccine.
Understanding HBV, its global prevalence, transmission routes, and the importance of vaccination is crucial in preventing the spread of this infectious disease and safeguarding public health.
